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A B S T R A C T
Secondary chronic open-angle glaucoma associated with pseudoexfoliation (PEX) syndrome accounts for approxi-
mately 25% of all glaucomas and represents the most common identifiable cause of glaucoma overall. Selective laser
trabeculoplasty (SLT) is effective in reducing intraocular pressure (IOP) in glaucomatous patients and has the advan-
tage of preserving surrounding structures. We report here SLT treatment of a 82 year old female with a secondary devel-
oped open-angle pseudoexfoliation glaucoma allergic to all anti glaucoma eye drops especially those which contain ben-
salconium chloridum as preservative. Since patient was allergic also to methyl-cellulose, we performed SLT with water
as a mediator. Patient had PEX syndrome for 10 years, immature cataracts on both eyes, and best corrected visual acuity
(BCVA) 0.7 on the right and 0.2 on the left eye. We have monitored intraocular pressure (IOP), the changes in the visual
field and optic nerve. Preoperative IOP was 28 mmHg on the right and 30 mmHg on the left eye. The follow up period
was 24 months with time points for measured parameters every 3 months. After 18 months IOP remained in the normal
values (average17 mmHg) on the right eye, but on the left eye it increased up to 28 mmHg. SLT re-treatment was carried
out on the left eye and the IOP stabilized again on the values between 16-18mmHg. There were no significant change in
the visual field and optic nerve configuration before and after SLT (C/D value for right eye:0.3–0.4; C/D left eye:0.5).
Based on this case report, SLT seems to be very effective treatment for maintaining regular IOP in patient with PEX who
is allergic to all types of medications.
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Introduction
PEX syndrome is a generalized process of the extra-
cellular matrix characterized by production and progres-
sive accumulation of an abnormal extracellular material
in many intra- and extraocular tissues. Pathogenetic con-
cept of PEX syndrome is a type of elastosis affecting par-
ticularly elastic microfibrils. Active involvement of the
trabecular meshwork (TM) in this characteristic matrix
process may lead to glaucoma development in 40–60% of
the patients1. PEX-associated open-angle glaucoma rep-
resents a relatively severe and progressive type of glau-
coma with a generally poor prognosis due to high intra-
ocular pressure levels and fluctuations in the diurnal
pressure curve. The primary cause of chronic pressure el-
evation appears to be local production of PEX material
by TM cells and Schlemm’s canal cells with subsequent
degenerative changes of Schlemm’s canal and juxtacana-
licular tissues. Additional pathogenetic factors contribu-
ting to pressure increase include pronounced melanin
dispersion, increased protein concentrations of the aque-
ous humor, vascular factors, and connective tissue alter-
ations of the lamina cribrosa1. Intraocular pressure
(IOP) decreasing is shown to diminish the progression of
the disease, and could be achieved by the chronic use of
hypotensive eyedrops, incisional surgery or laser trabe-
culoplasty2. Selective laser trabeculoplasty (SLT) is effec-
tive in reducing intraocular pressure (IOP) in such pa-
tients and has the advantage of preserving surrounding
structures3. This treatment consists of application of la-
ser spots in the TM, leading to an increase in the outflow
facility through it and in consequence, decreasing IOP.
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Selective photothermolysis takes place when thermal
damage is confined to the target, melanin, by using a spe-
cific laser wavelength with a laser exposure time (3 ns)
equal to or shorter than the thermal reaction time of
melanin. Thus, pulsed lasers with low threshold radiant
exposures can selectively target pigmented TM cells and
avoid collateral thermal damage to adjacent nonpigmen-
ted cells4. SLT does not depend on chronic instillation of
eyedrops, as does medical treatment, and also does not
have too many complications, as does incisional surgery2.
Since our patient was allergic to any glaucomatous drops
we performed SLT, estimated as the best therapy modal-
ity.
Materials and Methods
Case report. A 82 year old female, allergic to all
antiglaucoma eye drops especially those which contain
bensalconium chloridum as preservative, presented to us
with a secondary developed open-angle pseudoexfoliation
glaucoma. Patient had PEX syndrome for 10 years, im-
mature cataracts on both eyes, and BCVA 0.7 on the
right and 0.2 on the left eye. Patient was also allergic to
methyl-cellulose, so we performed SLT with water as a
mediator. Preoperatively IOP was 28 mmHg on the right
and 30 mmHg on the left eye. SLT was performed using a
frequency doubled (532 nm) q switched Nd:YAG (Ellex
Solo) laser which creates a spot size of 400 mm4. We moni-
tored intraocular pressure (IOP), the changes in the vi-
sual field and optic nerve for 24 months with check
points every 3 months. The used apparatus were, com-
puterized visual field-OCTOPUS and optical coherence
tomography (OCT-Zeiss).
Results
On the first day after SLT, IOP of the right eye de-
creased from 28 mmHg to 18mmHg and on the left eye
from 30 mmHg to 20 mmHg. While IOP on the right eye
remained in the normal values (average 17mmHg) for
whole follow up period of 24 months, on the left eye it in-
creased up to 28 mmHg 18 months after treatment. SLT
re-treatment was carried out on the left eye and the IOP
stabilized again on the values between 16–18mmHg (Fig-
ure 1). There were no significant changes in the visual
field and optic nerve configuration before and after SLT
(C/D value for right eye:0.3–0.4; C/D left eye:0.5) (Figure
2). Patient had cataract on both eyes, left predominating,
and BCVA also did not significantly change after the SLT
treatment, remaining 0.7 on the right eye and 0.2 on the
left eye.
Discussion
The current pathogenetic concept describes PEX as
an elastic microfibrillopathy involving TGF-betal, oxida-
tive stress and impaired cellular protection mechanisms
as a key pathogenetic factors. The pathogenetic factors
TGF-b1 and TIMP-1/2 appear to be causally involved in
this fibrotic process and thus may represent potential
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Fig. 1. Intraocular pressure in both eyes for follow up period of
24 months. IOP – intraocular pressure, SLT – selective laser tra-
beculoplasty, Preop-preoperative, D – day, Mo – month, Reop-re-
operation
Fig. 2. OCT measurement of left eye optic disc before (A) and one year after SLT treatment (B).
OCT – optical coherence tomography, SLT – selective laser trabeculoplasty.
a)) b))
targets for specific, rational therapeutic approaches2. Al-
though there is no evidence to determine the effective-
ness of laser trabeculoplasty compared to contemporary
medication (prostaglandin analogues, topical anhydrase
inhibitors and alpha2-agonists) and also with contempo-
rary surgical techniques, evidence suggests that, in peo-
ple with newly diagnosed secondary open angle glau-
coma, the risk of uncontrolled IOP is higher in people
treated with medication when compared to laser trabecu-
loplasty at two years follow up1. Although, it is also well
known that trabeculoplasty is less effective than trabe-
culectomy in controlling IOP at six months and two
years follow up. The literature has shown variable rates
of the short and long term efficacy of SLT, with mean re-
ductions in IOP ranging from 2–14 mmHg at 1 month,
3–6 mmHg at 3 months, and 5–7 mmHg at 6 months5–8. A
recent study has shown that SLT is a safe and effective
procedure with continued average IOP lowering over 3
months9. Coagulative damage to the TM has not been
reported10,11. Recent studies showed that patients who
had a baseline IOP >21 mmHg were more likely to have
a greater absolute value of IOP reduction and IOP reduc-
tion correlated with number of shots and average energy
delivered12,13. Results in our reported case confirm the
results of the previous studies. Since our patient was al-
lergic to drops with preservatives, including anestethic
drops, and methyl celulose, we performed SLT without
anaethesia and with water mediator and achieved ade-
quate laser shot energy. The IOP was succesfully de-
creased for the follow up of two years, with repeated
treatment on the left eye after 18 months. We conclude
that SLT seems to be very effective method for maintain-
ing regular IOP in the patient with PEX syndrome who
is allergic to all types of medications.
Abbreviations: PEX – Pseudoexfoliation (PEX) syn-
drome, SLT – Selective laser trabeculoplasty, IOP – intra-
ocular pressure, BCVA – best corrected visual acuity, C/D
– cup/ disc
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SELEKTIVNA LASERSKA TRABEKULOPLASTIKA U LIJE^ENJU PSEUDOEKSFOLIJATIVNOG
GLAUKOMA KOD PACIJENTA ALERGI^NOG NA KONZERVATVNU ANTIGLAUKOMSKU TERAPIJU
S A @ E T A K
Sekundarni glaukom otvorenog kuta kao posljedica pseudoeksfolijativnog sindroma (PEX-a) naj~e{}i je oblik glau-
koma poznatog uzroka i predstavlja 25% svih glaukoma uop}e. Selektivna laserska trabekuloplastika (SLT) u~inkovita
je metoda u sni`avanju o~nog tlaka u pacijenata s glaukomom te ima prednost o~uvanja okolnih mikrostruktura tkiva.
Prikazani su rezultati 82-godi{nje pacijentice s PEX glaukomom, alergi~nom na sve anti glaukomske kapi za o~i, pogo-
tovo one koje sadr`e bensalkonij-klorid kao konzervans. Kako je pacijentica bila alergi~na i na metil-celulozu, kao me-
dijator za SLT kori{tena je voda. Pacijentica boluje od PEX sindroma 10 godina, ima imaturne mrene na oba oka te
korigiranu vidnu o{trinu 0.7 na desnom te 0.2 na lijevom oku. Parametri koje smo pratili u lije~enju pacijentice su o~ni
tlak, promjene vidnog `ivca i vidnog polja. Preoperativni o~ni tlak bio je 28 mmHg na desnom te 30 mmHg na lijevom
oku. Vrijeme pra}enja pacijentice bilo je 24 mjeseca s vremenskim to~kama mjerenja ispitivanih parametara svakih 3
mjeseca. Nakon 18 mjeseci o~ni tlak bio je u normalnim vrijednostima u prosjeku 17 mmHg na desnom oku, dok je na
lijevom oku narastao na 28 mmHg. SLT je ponovljen na lijevom oku te se vrijednost o~nog tlaka normalizirao izme|u16
i 18 mmHg. Na vidnom polju i o~nom `ivcu nije bilo nikakvih o~ekivanih promjena prije i poslije terapije (C/D desno:
0.3–0.4; C/D lijevo: 0.5). Na temelju ovog prikazanog slu~aja mo`emo zaklju~iti da je SLT u~inkovit u odr`avanju nor-
malnog o~nog tlaka u pacijenta alergi~nog na ostale tipove antiglaukomskog lije~enja.
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